A C‐terminally amidated analogue of ShK is a potent and selective blocker of the voltage‐gated potassium channel Kv1.3

Overview of attention for article published in Febs Letters, October 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (84th percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

patent: 2 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 50 Mendeley

Summary Patents Wikipedia

So far, Altmetric has seen 2 patents that reference this research output.

Potassium channel blockers and use thereof in the treatment of autoimmune diseases

Application US-10246496-B2

United States of America

NOVEL POTASSIUM CHANNEL BLOCKERS AND USE THEREOF IN THE TREATMENT OF AUTOIMMUNE DISEASES

Application WO-2016023072-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.